Healthcare Lessons from the Data Sages at Strata
This article was first published on Strata. By Bonnie Feldman (@DrBonnie360) and Ellen M. Martin Most healthcare clinicians don’t often think about donating or sharing data. Yet, after hearing Stephen Friend of Sage Bionetworks talk about involving citizens and patients in the field of genetic research at StrataRx 2012, I was curious to learn more. McKinsey points out...
Europe’s First Award For A Social Campaign in Healthcare
Public Health is definitely not known for cutting edge communication. It’s about time to prove the world otherwise, thus Europe's largest social network for medical professionals, DocCheck, has put together an award to change this.
Efficiency vs. Effectiveness in Healthcare
The author of a recent NY Times opinion article, Gilbert Welch, argues that we are not putting enough effort into challenging standard practices in medicine, but instead focus too much on accommodating and streamlining those practices already established, and on coming up with ever new diagnostic and screening tools, treatments and procedures to spend health...
The KOL Of The Future
Key Opinion Leaders (KOL) are still one of the most important corner stones for the marketing machines of pharmaceutical companies. Their network, expertise, reach and authority is what pharma is interested in. We’ve written about KOL stardom in the past and how to attain it. In this post I’d like to take a closer look...
5 Elements Of A Pharma Company 2.0
In various posts we have been calling for a change within the pharmaceutical industry. Much of that is not new, yet still nothing seems to change on a bigger scale. Sure, the iPad is becoming an essentiell tool in sales, eDetails have emerged, biotech startups are being bought instead of inhouse R&D, but especially with...
Pharma Should Acquire Software Startups
The pharmaceutical industry has been dormant throughout the last decades when it comes to finding new business and sales models. The big ones have been keen on keeping competitors out of their businesses by close surveillance or legal action. In order to sustain and grow their revenue, the pharmaceutical industry has one of the most...
What is Pharma’s Sales Savior?
We've previously reported several times on the interaction between physicians and pharmaceutical companies. We've also argued to some extent the model is dead. Pharma reps are expensive and pharma has transitioned into a sales business,...
Doctors Know Sh*t
OK, this is a controversial headline, but it’s true – to some extent and in regards to certain things. We are not speaking of the medical profession obviosuly but from all these things that you, as a human being in the civilized world are surrounded with. In med school and as a physician you are...
Interview with Abbott’s Diabetes Head Asia Pacific: Andreas Amrein
After we’ve had an interview with the amazing and insightful Dr. Bryan Vartebedian as well as the inspirational Lisa Chu, we thought that we should also talk to somebody who’s on the pharma side of the healthcare industry. Dr. Andreas Amrein, who is the Senior Area Director for the Diabetes Unit of Abbott in Asia...
Who Owns the Content? The Future of Medical Publishing.
Education is one of MedCrunch’s favorite topics. These are great times to talk about education. The internet and mobile devices have liberated knowledge and democratized its distribution. Up until now, medical knowledge was owned or distributed by several entities: the experts who produce it, the universities, the publishers and the various medical societies. Moreover, the...
The Push and Pull of Pharma Marketing and What Physicians Can Do About it.
Pharmaceutical marketing that is directed towards physicians is called "push-marketing". Marketing directed towards patients is called "pull-marketing"...
The Truth about Placebos and Why You Should Care
Placebos are pivotal to modern medical research and practice. We've found this amazing video and some interesting facts.
